Guggenheim Capital LLC Axogen, Inc. Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
129Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$75.2 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$49.1 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$48.6 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$37 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $621M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...